Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04245891
Other study ID # IRB 17.11.01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 1, 2016
Est. completion date November 30, 2017

Study information

Verified date January 2020
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This retrospective study aims to evaluate the fate of children born by cesarean section under spinal anesthesia with or without norepinephrine as vasopressor support for anesthesia. The main objective is to compare the initial Apgar score. The records of patients who received norepinephrine are compared to those without norepinephrine. To limit the biases of this type of study, the investigators will apply a propensity score that will include as a variable: age, ASA score, comorbidity, urgency. The patients analysed correspond to the period 2016-2017.


Recruitment information / eligibility

Status Completed
Enrollment 265
Est. completion date November 30, 2017
Est. primary completion date November 30, 2017
Accepts healthy volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- age > 18

- Spinal Anesthesia for Cesarean Section

Exclusion Criteria:

- sub epidural cesarean section

- contraindication to spinal anesthesia (allergy, severe heart disease, coagulopathy)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Outcome

Type Measure Description Time frame Safety issue
Primary lactate level The primary endpoint is the Umbilical Cord Lactate levels Just after the birth of the newborn baby
Secondary APGAR Score APGAR Score 1, 5 and 10 minutes after birth
Secondary Umbilical Cord arterial PH Umbilical Cord arterial PH Just after the birth
Secondary Umbilical Cord venous PH Umbilical Cord venous PH Just after the birth
Secondary maternal arterial tension during cesarean section maternal arterial tension during cesarean section 0, 5,10,15, 20 25, 30,35,40 minutes after spinal anesthesia
Secondary incidences of mother nausea and vomiting incidences of mother nausea and vomiting from beginning to cesarean section end
Secondary use of vasopressors use of vasopressors from beginning to cesarean section end
See also
  Status Clinical Trial Phase
Recruiting NCT05213975 - Kinesio Taping Application After Cesarean Section N/A
Enrolling by invitation NCT06081374 - The Effect of Simulation-based Breastfeeding Education on Breastfeeding Self-efficacy and Breastfeeding Problems N/A
Not yet recruiting NCT03154866 - Lactobacillus Kefiri LKF01 (DSM32079) in Newborns Born by Caesarian Section Phase 4